In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 315 for your search:
Drug:  mesna
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9410, POG-SIMAL-8

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: NCI-85-C-62, NCI-T85-0096N, T85-0096

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: POG-8741/42, POG-8741, POG-8742

4.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 31
Sponsor: NCI
Protocol IDs: POG-8759

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1588

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: not over 30
Sponsor: NCI
Protocol IDs: CCG-7921, POG-9351, INT-0133

7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: GOG-149, GOG-0149

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9313, CLB-9394, E-S9313, NCCTG-933051, INT-0137

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: CDR0000063311, EORTC-06931, NCT00002549

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor: Other
Protocol IDs: HOG-LUN93-2, NCI-V94-0422

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 3 to 21
Sponsor: NCI
Protocol IDs: POG-9331, CCG-9932, INT-0140

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI, Other
Protocol IDs: CDR0000063574, MDA-DM-94017, NCI-T94-0040D, DM94-017, T94-0040, NCT00002565

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: FRE-FNCLCC-PALSAR-93, NCI-F94-0018

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor:
Protocol IDs: MRC-LU09, EU-94023

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: at least 1 + under 20 at diag.
Sponsor: NCI
Protocol IDs: CCG-1941

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 30 and under
Sponsor: NCI
Protocol IDs: POG-9354, CCG-7942, INT-0154

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-95088, RP-56976-TAX-320, NCI-V96-0830

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 15 at initial diagnosis
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-R2, EU-95039

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 1 and under 15
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-XI, EU-95036

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-LU20, EU-95041

21.

Phase: Phase III
Type: Health services research, Treatment
Status: Completed
Age: 16 to 65
Sponsor: Other
Protocol IDs: CDR0000064834, IBCSG-15-95, EU-96021, NCT00002784

22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 65
Sponsor: Other
Protocol IDs: UNMC-35195, NCI-V96-0918

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor:
Protocol IDs: GER-NB90, EU-96004, NCT00002802

24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: E-2493, E2493

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: MRC-LU21, EU-96019, NCT00002822
1     
New Search